MEGANNE GERWIN: Open Payments
NPI 1962710566 · PORT HURON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,286 in 105 payments from 16 companies in 2025. Trend: 2023 $898 · 2024 $1,722 · 2025 $2,286
Food & beverage: $2,213Education: $74
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 11 | $406 |
| Janssen Biotech, Inc. | 21 | $383 |
| ABBVIE INC. | 15 | $311 |
| Novartis Pharmaceuticals Corporation | 16 | $227 |
| Regeneron Healthcare Solutions, Inc. | 8 | $208 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $128 |
| Galderma Laboratories, L.P. | 4 | $124 |
| Lilly USA, LLC | 5 | $89 |
| Organon LLC | 3 | $77 |
| E.R. Squibb & Sons, L.L.C. | 3 | $65 |
Products named: DUPIXENT, TREMFYA, SKYRIZI, COSENTYX, NEMLUVIO, ILUMYA, TALTZ, Sotyktu.
Industry payments across MI — which companies pay providers there.
